skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: resource type: Standards remove subject: Clinical Medicine remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
Material Type:
Standards
Add to My Research

Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

2
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy
Material Type:
Standards
Add to My Research

Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

3
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders
Material Type:
Standards
Add to My Research

Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

4
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable
Material Type:
Standards
Add to My Research

Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

5
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer
Material Type:
Standards
Add to My Research

Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

6
Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy
Material Type:
Standards
Add to My Research

Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy

NICE Guidance, 2020

Copyrights: © NICE 2020 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

7
Avelumab with axitinib for untreated advanced renal cell carcinoma
Material Type:
Standards
Add to My Research

Avelumab with axitinib for untreated advanced renal cell carcinoma

NICE Guidance, 2020

Copyrights: © NICE 2020 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

8
Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis
Material Type:
Standards
Add to My Research

Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

9
Midostaurin for untreated acute myeloid leukaemia
Material Type:
Standards
Add to My Research

Midostaurin for untreated acute myeloid leukaemia

NICE Guidance, 2018

Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

10
Tocilizumab for treating giant cell arteritis
Material Type:
Standards
Add to My Research

Tocilizumab for treating giant cell arteritis

NICE Guidance, 2018

Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

11
Ceritinib for untreated ALK-positive non-small-cell lung cancer
Material Type:
Standards
Add to My Research

Ceritinib for untreated ALK-positive non-small-cell lung cancer

NICE Guidance, 2018

Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2018  (1)
  2. 2018 To 2018  (3)
  3. 2019 To 2019  (1)
  4. 2020 To 2021  (4)
  5. After 2021  (3)
  6. More options open sub menu

Searching Remote Databases, Please Wait